Connecteve

About Connecteve

Connecteve is a South Korean MedTech firm developing an end-to-end orthopedic solution powered by artificial intelligence and robotics. Founded in 2021 by Dr. Doohyun Noh, an orthopedic surgeon and associate professor at Seoul National University Hospital, the company was born from his direct clinical experience and perceived need to systematize repetitive diagnostic and treatment patterns. Dr. Noh's journey from a science high school graduate to an accomplished orthopedic surgeon, with extensive training at Seoul National University, provided him with the necessary insights into the practical challenges and opportunities for technological integration in healthcare.

The company targets the growing market of musculoskeletal disorders, which affect a significant portion of the aging global population. Connecteve develops solutions for healthcare providers, primarily orthopedic surgeons and hospitals, aiming to improve the entire clinical workflow from diagnosis to post-operative care. Its business model centers on providing these institutions with AI-driven software and next-generation surgical robots, intending to generate revenue through the sale and licensing of these technologies.

Connecteve's product suite seeks to create a comprehensive digital ecosystem for orthopedic care. Key offerings include AI-based software that assists in the interpretation of medical images like X-rays (CONNEVO KOA, ALI) and a platform for patient consultation and surgical planning (CONNEVO Suite). This software is built upon a high-quality database of over 100,000 medical images labeled by specialist physicians. A primary benefit is the reduction of manual, repetitive tasks for clinicians, allowing for more precise and consistent decision-making. The company is also developing a next-generation surgical robot, slated for a 2027 release, designed to enhance the accuracy of procedures like artificial joint surgery to as high as 95%. By integrating AI software with robotics, Connecteve aims to shorten surgery times and reduce the complexities of surgical planning.

The firm has achieved significant milestones, including securing substantial funding and government support. It raised KRW 4 billion in a pre-Series A round in early 2024 and followed up with a KRW 14 billion (approx. $10.5 million) Series A round in February 2025. Investors include DSC Investment, Stonebridge Ventures, and IMM Investment, among others, with Bumin Hospital participating as a strategic investor to collaborate on commercialization. Connecteve has also been selected for prominent national R&D projects like the 'DeepTech TIPS' program and has secured around $3 million in government grants. The company is actively pursuing global expansion, with CE certification for Europe underway, and is also seeking regulatory approval in Singapore, Japan, and the United States.